GSK3B and melanoma: Western blot analysis further confirmed these findings, demonstrating that fisetin treatment elevated the expression of phosphorylated PI3K, Akt, and GSK3β by approximately 1.2-, 2-, and 2-fold, respectively, in melanoma cells.